A detailed history of Quest Partners LLC transactions in Xencor Inc stock. As of the latest transaction made, Quest Partners LLC holds 8,425 shares of XNCR stock, worth $171,954. This represents 0.03% of its overall portfolio holdings.

Number of Shares
8,425
Previous 2,862 194.37%
Holding current value
$171,954
Previous $60.8 Million 206.85%
% of portfolio
0.03%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$18.65 - $26.52 $103,749 - $147,530
5,563 Added 194.37%
8,425 $186 Million
Q4 2023

Feb 09, 2024

BUY
$16.53 - $21.42 $47,308 - $61,304
2,862 New
2,862 $60.8 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.22B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.